tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Advertisement

Oncopeptides AB (ONCO) Revenue

Compare
6 Followers

Oncopeptides AB Revenue

Oncopeptides AB had a revenue of 19.18M in the quarter ending Jun 30, 2025, with 44.59%. This bring the company's revenue in the last twelve months to 50.87M, Decreased 27.68%. In the fiscal year ending Dec 31, 2024, Oncopeptides AB had annual revenue of 31.65M with -10.14% growth.
Revenue (ttm)
50.87M
Revenue Growth
138.11%
P/S Ratio
43.00
Revenue/Employee
kr395,600
Employees
80
Market Cap
kr1.36B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
31.65M-3.57M+89.86%
Dec 31, 2023
35.22M26.86M+421.54%
Dec 31, 2022
8.36M-109.94M+7.06%
Dec 31, 2021
118.30M-11,829,500,000.00%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis